These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

447 related articles for article (PubMed ID: 34956172)

  • 1. Epstein-Barr Virus Epithelial Cancers-A Comprehensive Understanding to Drive Novel Therapies.
    Han S; Tay JK; Loh CJL; Chu AJM; Yeong JPS; Lim CM; Toh HC
    Front Immunol; 2021; 12():734293. PubMed ID: 34956172
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epstein-Barr Virus Induces Adipocyte Dedifferentiation to Modulate the Tumor Microenvironment.
    Liu SC; Tsang NM; Lee PJ; Sui YH; Huang CH; Liu TT
    Cancer Res; 2021 Jun; 81(12):3283-3294. PubMed ID: 33824135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EBV miRNAs BART11 and BART17-3p promote immune escape through the enhancer-mediated transcription of PD-L1.
    Wang J; Ge J; Wang Y; Xiong F; Guo J; Jiang X; Zhang L; Deng X; Gong Z; Zhang S; Yan Q; He Y; Li X; Shi L; Guo C; Wang F; Li Z; Zhou M; Xiang B; Li Y; Xiong W; Zeng Z
    Nat Commun; 2022 Feb; 13(1):866. PubMed ID: 35165282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel Therapies Boosting T Cell Immunity in Epstein Barr Virus-Associated Nasopharyngeal Carcinoma.
    Renaud S; Lefebvre A; Mordon S; Moralès O; Delhem N
    Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32560253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Understanding the interplay between host immunity and Epstein-Barr virus in NPC patients.
    Shen Y; Zhang S; Sun R; Wu T; Qian J
    Emerg Microbes Infect; 2015 Mar; 4(3):e20. PubMed ID: 26038769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accumulation of LOX-1
    Li X; Li JL; Jiang N; Chen J; Liang ZM; Zhao ZL; Xing YF
    Aging (Albany NY); 2020 Dec; 13(1):437-449. PubMed ID: 33290259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimating the global burden of Epstein-Barr virus-related cancers.
    Wong Y; Meehan MT; Burrows SR; Doolan DL; Miles JJ
    J Cancer Res Clin Oncol; 2022 Jan; 148(1):31-46. PubMed ID: 34705104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High Levels of Antibody that Neutralize B-cell Infection of Epstein-Barr Virus and that Bind EBV gp350 Are Associated with a Lower Risk of Nasopharyngeal Carcinoma.
    Coghill AE; Bu W; Nguyen H; Hsu WL; Yu KJ; Lou PJ; Wang CP; Chen CJ; Hildesheim A; Cohen JI
    Clin Cancer Res; 2016 Jul; 22(14):3451-7. PubMed ID: 26920891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Associations between environmental factors and serological Epstein-Barr virus antibodies in patients with nasopharyngeal carcinoma in South China.
    Zhou T; Yang DW; He YQ; Xue WQ; Liao Y; Zheng MQ; Jia YJ; Yuan LL; Zhang WL; Zeng YX; Jia WH
    Cancer Med; 2019 Aug; 8(10):4852-4866. PubMed ID: 31241250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The promise of a prophylactic Epstein-Barr virus vaccine.
    Balfour HH; Schmeling DO; Grimm-Geris JM
    Pediatr Res; 2020 Jan; 87(2):345-352. PubMed ID: 31641280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between Antibody Responses to Epstein-Barr Virus Glycoproteins, Neutralization of Infectivity, and the Risk of Nasopharyngeal Carcinoma.
    Zhu QY; Kong XW; Sun C; Xie SH; Hildesheim A; Cao SM; Zeng MS
    mSphere; 2020 Dec; 5(6):. PubMed ID: 33268566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epstein-Barr virus and human papillomavirus serum antibodies define the viral status of nasopharyngeal carcinoma in a low endemic country.
    Simon J; Schroeder L; Ingarfield K; Diehl S; Werner J; Brenner N; Liu Z; Pawlita M; Pring M; Butt J; Ness A; Waterboer T
    Int J Cancer; 2020 Jul; 147(2):461-471. PubMed ID: 32279316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of Epstein-Barr Virus Serological Tools for the Screening and Risk Assessment of Nasopharyngeal Carcinoma: a Large Population-based Study.
    Guo J; Cui Z; Zheng Y; Li X; Chen Y
    Pathol Oncol Res; 2020 Oct; 26(4):2185-2190. PubMed ID: 32222897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EBV+ tumors exploit tumor cell-intrinsic and -extrinsic mechanisms to produce regulatory T cell-recruiting chemokines CCL17 and CCL22.
    Jorapur A; Marshall LA; Jacobson S; Xu M; Marubayashi S; Zibinsky M; Hu DX; Robles O; Jackson JJ; Baloche V; Busson P; Wustrow D; Brockstedt DG; Talay O; Kassner PD; Cutler G
    PLoS Pathog; 2022 Jan; 18(1):e1010200. PubMed ID: 35025968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic variants in NKG2D axis and susceptibility to Epstein-Barr virus-induced nasopharyngeal carcinoma.
    Viet NH; Trung NQ; Dong LT; Trung LQ; Espinoza JL
    J Cancer Res Clin Oncol; 2021 Mar; 147(3):713-723. PubMed ID: 33392659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Role of NK Cells in EBV Infection and EBV-Associated NPC.
    Png YT; Yang AZY; Lee MY; Chua MJM; Lim CM
    Viruses; 2021 Feb; 13(2):. PubMed ID: 33671917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epstein-Barr virus and nasopharyngeal carcinoma.
    Young LS; Dawson CW
    Chin J Cancer; 2014 Dec; 33(12):581-90. PubMed ID: 25418193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cigarette smoking increases the risk of nasopharyngeal carcinoma through the elevated level of IgA antibody against Epstein-Barr virus capsid antigen: A mediation analysis.
    Hsu WL; Chien YC; Huang YT; Yu KJ; Ko JY; Lin CY; Tsou YA; Leu YS; Liao LJ; Chang YL; Su JY; Liu Z; Wang CP; Terng SD; Hua CH; Lee JC; Yang TL; Kate Hsiao CH; Wu MS; Tsai MH; Liu MJ; Lou PJ; Hildesheim A; Chen CJ;
    Cancer Med; 2020 Mar; 9(5):1867-1876. PubMed ID: 31925935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Diagnostics of nasopharyngeal carcinoma with Epstein-Barr virus (Herpesviridae, Lymphocryptovirus, HHV-4) serological and molecular markers in cases of undetected primary tumor location.].
    Senyuta NB; Smirnova KV; Kondratova VN; Ignatova AV; Mudunov AM; Dushenkina TE; Liechtenstein AV; Gurtsevich VE
    Vopr Virusol; 2019; 64(5):229-237. PubMed ID: 32167688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Role of LMP1 in Epstein-Barr Virus-associated Gastric Cancer.
    Huang X; Zhang M; Zhang Z
    Curr Cancer Drug Targets; 2024; 24(2):127-141. PubMed ID: 37183458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.